ADDITION OF SULFONYLUREA TO INSULIN-TREATMENT IN POORLY CONTROLLED TYPE-II DIABETES - A DOUBLE-BLIND, RANDOMIZED CLINICAL-TRIAL

被引：36
作者：
SCHADE, DS
MITCHELL, WJ
GRIEGO, G
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1987年 / 257卷 / 18期
关键词：
D O I：
10.1001/jama.257.18.2441
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2441 / 2445
页数：5
相关论文
共 29 条
[1]   TREATMENT OF POORLY REGULATED NON-INSULIN-DEPENDENT DIABETES-MELLITUS WITH COMBINATION INSULIN-SULFONYLUREA [J].
ALLEN, BT ;
FEINGLOS, MN ;
LEBOVITZ, HE .
ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (10) :1900-1903
[2]  
BODEN G, 1985, AM J MED S2B, V979, P23
[3]  
DeFronzo R A, 1983, Am J Med, V74, P52, DOI 10.1016/0002-9343(83)90654-X
[4]  
Eaton R P, 1978, Diabetes Care, V1, P40, DOI 10.2337/diacare.1.1.40
[5]   HEPATIC REMOVAL OF INSULIN IN NORMAL MAN - DOSE-RESPONSE TO ENDOGENOUS INSULIN-SECRETION [J].
EATON, RP ;
ALLEN, RC ;
SCHADE, DS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 56 (06) :1294-1300
[6]   RECEPTOR DEPLETION IN DIABETES-MELLITUS - CORRECTION WITH THERAPY [J].
EATON, RP ;
GALAGAN, R ;
KAUFMAN, E ;
ALLEN, RC ;
RUSSELL, L ;
MILLER, F .
DIABETES CARE, 1981, 4 (02) :299-304
[7]  
ELKELES RS, 1982, DIABETES CARE, V5, P427, DOI 10.2337/diacare.5.4.427
[8]  
FABRYKANT M, 1957, METABOLISM, V6, P509
[9]  
FABRYKANT M, 1958, METABOLISM, V7, P213
[10]   ENDOCRINE AND METABOLIC EFFECTS OF GLYBENCLAMIDE - EVIDENCE FOR AN EXTRAPANCREATIC MECHANISM OF ACTION [J].
FELDMAN, JM ;
LEBOVITZ, HE .
DIABETES, 1971, 20 (11) :745-&
123